Plants as a Novel Dietary Supplement and Medicine

A special issue of Plants (ISSN 2223-7747).

Deadline for manuscript submissions: 31 July 2024 | Viewed by 1166

Special Issue Editor


E-Mail Website
Guest Editor
Graduate Program of Nutrition Science, National Taiwan Normal University, Taipei 11677, Taiwan
Interests: natural products; herbs; bioactivities; therapeutics; health food; diabetes; non-alcoholic fatty liver disease
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Since ancient times, plants have been a significant source of principles with biological property and some of which are beneficial for human health. Plants have thus served as the foundation of dietary supplement and traditional medicine systems. In recent years, plants have been intensively explored and studied for their therapeutic potential such as anticancer, antiviral, antimicrobial, antioxidant, antihyperglycemic, anti-inflammatory, antiseptic, etc. activities. However, many natural compounds from plants beneficial for human health and their mechanisms of action remain undiscovered. Nowadays, new insights into dietary supplement and medicine of plants are still needed to better understand their intrinsic complexity and exploit their vast commercial potential. In this Special Issue, articles (original research papers, perspectives, hypotheses, opinions, reviews, modelling approaches, and methods) that focus on studies of modern cosmetic, functional food, dietary supplement and medicine from plants are most welcome.

Prof. Dr. Szu-Chuan Shen
Guest Editor

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Plants is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • therapeutic potential
  • functional food
  • dietary supplement
  • medicine
  • plant

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Research

14 pages, 4236 KiB  
Article
Therapeutic Application of Dendrobium fimbriatum Hook for Retinopathy Caused by Ultraviolet Radiation and Chemotherapy Using ARPE-19 Cells and Mouse Retina
by Chi-Feng Cheng, Sheue-Er Wang, Chen-Wen Lu, Thi Kim Ngan Nguyen, Szu-Chuan Shen, Chia-Ying Lien, Wu-Chang Chuang, Ming-Chung Lee and Chung-Hsin Wu
Plants 2024, 13(5), 617; https://doi.org/10.3390/plants13050617 - 23 Feb 2024
Viewed by 907
Abstract
Retinopathy caused by ultraviolet radiation and cancer chemotherapy has increased dramatically in humans due to rapid environmental and social changes. Therefore, it is very important to develop therapeutic strategies to effectively alleviate retinopathy. In China, people often choose dendrobium to improve their eyesight. [...] Read more.
Retinopathy caused by ultraviolet radiation and cancer chemotherapy has increased dramatically in humans due to rapid environmental and social changes. Therefore, it is very important to develop therapeutic strategies to effectively alleviate retinopathy. In China, people often choose dendrobium to improve their eyesight. In this study, we explored how Dendrobium fimbriatum extract (DFE) protects ARPE-19 cells and mouse retinal tissue from damage of ultraviolet (UV) radiation and chemotherapy. We evaluated the antioxidant capacity of DFE using the 1,1-diphenyl-2-trinitophenylhydrazine (DPPH) assay. The protective effects of DEF from UV- and oxaliplatin (OXA)-induced damage were examined in ARPE-19 cells using 3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay and immunofluorescence (IF) stains, and in mouse retinal tissue using immunohistochemistry (IHC) stains. Our results show that DFE has excellent antioxidant capacity. The ARPE-19 cell viability was decreased and the F-actin cytoskeleton structure was damaged by UV radiation and OXA chemotherapy, but both were alleviated after the DFE treatment. Furthermore, DFE treatment can alleviate OXA chemotherapy-induced reduced expressions of rhodopsin and SOD2 and increased expressions of TNF-α and caspase 3 in mouse retinal tissue. Thus, we suggest that DFE can act as suitable treatment for retinopathy through reducing oxidative stress, inflammation, and apoptosis. Full article
(This article belongs to the Special Issue Plants as a Novel Dietary Supplement and Medicine)
Show Figures

Graphical abstract

Back to TopTop